233 related articles for article (PubMed ID: 33356695)
61. Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation.
Magerus-Chatinet A; Neven B; Stolzenberg MC; Daussy C; Arkwright PD; Lanzarotti N; Schaffner C; Cluet-Dennetiere S; Haerynck F; Michel G; Bole-Feysot C; Zarhrate M; Radford-Weiss I; Romana SP; Picard C; Fischer A; Rieux-Laucat F
J Clin Invest; 2011 Jan; 121(1):106-12. PubMed ID: 21183795
[TBL] [Abstract][Full Text] [Related]
62. Autoimmune lymphoproliferative syndrome due to FAS mutations outside the signal-transducing death domain: molecular mechanisms and clinical penetrance.
Hsu AP; Dowdell KC; Davis J; Niemela JE; Anderson SM; Shaw PA; Rao VK; Puck JM
Genet Med; 2012 Jan; 14(1):81-9. PubMed ID: 22237435
[TBL] [Abstract][Full Text] [Related]
63. Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS).
Teachey DT; Manno CS; Axsom KM; Andrews T; Choi JK; Greenbaum BH; McMann JM; Sullivan KE; Travis SF; Grupp SA
Blood; 2005 Mar; 105(6):2443-8. PubMed ID: 15542578
[TBL] [Abstract][Full Text] [Related]
64. Somatic loss of heterozygosity, but not haploinsufficiency alone, leads to full-blown autoimmune lymphoproliferative syndrome in 1 of 12 family members with FAS start codon mutation.
Hauck F; Magerus-Chatinet A; Vicca S; Rensing-Ehl A; Roesen-Wolff A; Roesler J; Rieux-Laucat F
Clin Immunol; 2013 Apr; 147(1):61-68. PubMed ID: 23524443
[TBL] [Abstract][Full Text] [Related]
65. An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome.
Straus SE; Sneller M; Lenardo MJ; Puck JM; Strober W
Ann Intern Med; 1999 Apr; 130(7):591-601. PubMed ID: 10189330
[TBL] [Abstract][Full Text] [Related]
66. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
[TBL] [Abstract][Full Text] [Related]
67. Janus Kinase Inhibitor Tofacitinib Shows Potent Efficacy in a Mouse Model of Autoimmune Lymphoproliferative Syndrome (ALPS).
Yokoyama S; Perera PY; Terawaki S; Watanabe N; Kaminuma O; Waldmann TA; Hiroi T; Perera LP
J Clin Immunol; 2015 Oct; 35(7):661-7. PubMed ID: 26453583
[TBL] [Abstract][Full Text] [Related]
68. Lymphoproliferative syndrome with autoimmunity: A possible genetic basis for dominant expression of the clinical manifestations.
Rieux-Laucat F; Blachère S; Danielan S; De Villartay JP; Oleastro M; Solary E; Bader-Meunier B; Arkwright P; Pondaré C; Bernaudin F; Chapel H; Nielsen S; Berrah M; Fischer A; Le Deist F
Blood; 1999 Oct; 94(8):2575-82. PubMed ID: 10515860
[TBL] [Abstract][Full Text] [Related]
69. The contribution of rare copy number variants in FAS toward pathogenesis of autoimmune lymphoproliferative syndrome.
Jevtich K; Price S; Similuk M; Kulm E; Yan J; Setzer M; Jamal L; Franco LM; Ghosh R; Walkiewicz M; Rao VK
Blood Adv; 2022 Jul; 6(13):3974-3978. PubMed ID: 35476126
[TBL] [Abstract][Full Text] [Related]
70. 18F-FDG PET Imaging Features of Patients With Autoimmune Lymphoproliferative Syndrome.
Carrasquillo JA; Chen CC; Price S; Whatley M; Avila NA; Pittaluga S; Jaffe ES; Rao VK
Clin Nucl Med; 2019 Dec; 44(12):949-955. PubMed ID: 31689275
[TBL] [Abstract][Full Text] [Related]
71. Cytomegalovirus infection in infants with autoimmune lymphoproliferative syndrome (ALPS).
Arkwright PD; Rieux-Laucat F; Le Deist F; Stevens RF; Angus B; Cant AJ
Clin Exp Immunol; 2000 Aug; 121(2):353-7. PubMed ID: 10931153
[TBL] [Abstract][Full Text] [Related]
72. A FAS-ligand variant associated with autoimmune lymphoproliferative syndrome in cats.
Aberdein D; Munday JS; Gandolfi B; Dittmer KE; Malik R; Garrick DJ; Lyons LA;
Mamm Genome; 2017 Feb; 28(1-2):47-55. PubMed ID: 27770190
[TBL] [Abstract][Full Text] [Related]
73. Rare splicing defects of FAS underly severe recessive autoimmune lymphoproliferative syndrome.
Agrebi N; Ben-Mustapha I; Matoussi N; Dhouib N; Ben-Ali M; Mekki N; Ben-Ahmed M; Larguèche B; Ben Becher S; Béjaoui M; Barbouche MR
Clin Immunol; 2017 Oct; 183():17-23. PubMed ID: 28668589
[TBL] [Abstract][Full Text] [Related]
74. Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation.
Takagi M; Shinoda K; Piao J; Mitsuiki N; Takagi M; Matsuda K; Muramatsu H; Doisaki S; Nagasawa M; Morio T; Kasahara Y; Koike K; Kojima S; Takao A; Mizutani S
Blood; 2011 Mar; 117(10):2887-90. PubMed ID: 21063026
[TBL] [Abstract][Full Text] [Related]
75. Autoimmune lymphoproliferative syndrome type III, an indefinite disorder.
van der Werff ten Bosch J; Otten J; Thielemans K
Leuk Lymphoma; 2001 May; 41(5-6):501-11. PubMed ID: 11378568
[TBL] [Abstract][Full Text] [Related]
76. Role of inherited defects decreasing Fas function in autoimmunity.
Dianzani U; Chiocchetti A; Ramenghi U
Life Sci; 2003 May; 72(25):2803-24. PubMed ID: 12697265
[TBL] [Abstract][Full Text] [Related]
77. Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency.
Rensing-Ehl A; Völkl S; Speckmann C; Lorenz MR; Ritter J; Janda A; Abinun M; Pircher H; Bengsch B; Thimme R; Fuchs I; Ammann S; Allgäuer A; Kentouche K; Cant A; Hambleton S; Bettoni da Cunha C; Huetker S; Kühnle I; Pekrun A; Seidel MG; Hummel M; Mackensen A; Schwarz K; Ehl S
Blood; 2014 Aug; 124(6):851-60. PubMed ID: 24894771
[TBL] [Abstract][Full Text] [Related]
78. Novel Germline TET2 Mutations in Two Unrelated Patients with Autoimmune Lymphoproliferative Syndrome-Like Phenotype and Hematologic Malignancy.
López-Nevado M; Ortiz-Martín J; Serrano C; Pérez-Saez MA; López-Lorenzo JL; Gil-Etayo FJ; Rodríguez-Frías E; Cabrera-Marante O; Morales-Pérez P; Rodríguez-Pinilla MS; Manso R; Salgado-Sánchez RN; Cerdá-Montagud A; Quesada-Espinosa JF; Gómez-Rodríguez MJ; Paz-Artal E; Muñoz-Calleja C; Arranz-Sáez R; Allende LM
J Clin Immunol; 2023 Jan; 43(1):165-180. PubMed ID: 36066697
[TBL] [Abstract][Full Text] [Related]
79. Synergistic defects of novo FAS and homozygous UNC13D leading to autoimmune lymphoproliferative syndrome-like disease: A 10-year-old Chinese boy case report.
Gu H; Ma J; Chen Z; Wang J; Zhang R; Wu R
Gene; 2018 Sep; 672():45-49. PubMed ID: 29864493
[TBL] [Abstract][Full Text] [Related]
80. [A case of autoimmune lymphoproliferactive syndrome and literature review].
Liu L; Hu J; Ma J; Li X; Li F; Li C
Zhonghua Er Ke Za Zhi; 2014 Dec; 52(12):923-6. PubMed ID: 25619350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]